SCHEMBL24374409

SCHEMBL24374409

CCC[C@H](CC1(C(=O)Nc2nnc(CC)s2)CCCC1)[PH](=O)O

nearest known ligand 0.70

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
MME P08473 16/20 0.70
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
GAA P10253 1/20 0.44
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43
ATM Q13315 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5924929 0.83 MME (1.00) MME
SCHEMBL5924982 0.83 MME (1.00) MME
SCHEMBL5924746 0.83 MME (1.00) MME
SCHEMBL7449382 0.78 MME (0.74) MMENPC1RAB9A
SCHEMBL7449384 0.75 MME (0.85) MME
SCHEMBL6940693 0.74 MME (0.73) MMEHSD17B10ATM
SCHEMBL6940695 0.74 MME (0.73) MMEHSD17B10ATM
SCHEMBL7446213 0.72 MME (0.79) MME
SCHEMBL7446151 0.72 MME (1.00) MME
SCHEMBL7449394 0.69 MME (0.60) MMENPC1RAB9AGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3280729-B1 CD20 THERAPIES, CD22 THERAPIES, AND COMBINATION THERAPIES WITH A CD19 CHIMERIC ANTIGEN RECEPTOR (CAR) - EXPRESSING CELL NOVARTIS AG (CH) 2022-04-27 EP disclosed